GLP-1 drugs, AI shopping to drive food consumption, says Magnum CEO Peter ter KulveGLP-1 drugs and AI shopping will drive future food consumption globally. India, China, and the US are already experiencing these significan...
European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...
Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelinesPharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug r...
Novo partners with Anthropic to speed up drug development with ClaudeThe Danish drugmaker will initially test Anthropic models and Claude Science in its research and development workflows, and address scienti...
Vimal Elaichi case: Delhi HC rejects makers' plea against FDA notices to Shah Rukh Khan, Ajay Devgn & Tiger ShroffThe Delhi High Court has ruled against the Vimal Elaichi makers, dismissing their plea regarding Maharashtra FDA notices aimed at celebriti...
BRICS adopts New Delhi Declaration: Inside the 140-point document on Global South's ambitionsBRICS leaders adopted the New Delhi Declaration at the 18th summit, reaffirming their commitment to cooperation, multilateralism and a more...
Delhi HC to pass order on Monday on Vimal Elaichi makers' plea seeking to quash show-cause notices against actorsThe Delhi High Court will soon decide on its jurisdiction to hear a plea. This plea challenges show-cause notices issued to Vimal Elaichi b...
Trump’s ‘Golden Age’ confronts economic angst that threatens GOPRepublican leaders express confidence in the economy's performance. However, voter polls reveal significant anxiety about current economic ...
Awarapan 2 OTT release update: When and where will Emraan Hashmi's box office hit sequel stream onlineEmraan Hashmi returns as Shivam Pandit in Awarapan 2, nearly two decades after the original film. The sequel has made a strong start at the...
Stocks in news: Tata Motors, RVNL, Eicher Motors, Mazagon Dock and LupinIndian equity markets experienced volatility, with the Nifty 50 extending its losing streak for four weeks. Escalating US-Iran hostilities ...
Jack Daniel's maker misses sales estimates on weak consumer spendingBrown-Forman's first-quarter sales fell short of expectations, yet the company reaffirmed its annual financial goals. Economic worries from...
Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
Fortis Healthcare reviews Delhi HC ruling in Daiichi Sankyo case, may approach Supreme CourtIn a significant development, Fortis Healthcare is assessing a recent decision from the Delhi High Court regarding the Daiichi Sankyo arbit...
Oncology firm Novocure says cyberattack exposed US patient recordsThe breach adds to a growing number of cyberattacks on the healthcare sector, including medical device makers Abbott, Stryker Medtronic a...